Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 7 months
- Director since
- 2026
7 months of board service in total across 1 board, counting each seat separately. Longest: Abeona Therapeutics Inc., 7 months.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Abeona Therapeutics Inc. June 12, 202695.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Syndax Pharmaceuticals Inc. | Open-market sale | −1,177 | $18.99 | $22,351 |
| Apr 1, 2026 | Abeona Therapeutics Inc. | Grant or award | +32,751 | — | — |
Questions about Keith A. Goldan
What boards is Keith A. Goldan on?
Keith A. Goldan sits on the board of Abeona Therapeutics Inc.
How long has Keith A. Goldan served on boards?
Our records show at least 7 months of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.